Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

MASS

908 Devices (MASS)

908 Devices Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MASS
DateHeureSourceTitreSymboleSociété
05/03/202500h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MASS908 Devices Inc
04/03/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MASS908 Devices Inc
04/03/202513h30GlobeNewswire Inc.Repligen Purchases Bioprocessing Analytics Portfolio from 908 DevicesNASDAQ:MASS908 Devices Inc
14/02/202517h23Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MASS908 Devices Inc
14/01/202522h01Business Wire908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:MASS908 Devices Inc
19/12/202413h00Business WireGetinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture ParametersNASDAQ:MASS908 Devices Inc
12/11/202413h00Business Wire908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue OutlookNASDAQ:MASS908 Devices Inc
04/11/202413h00Business Wire908 Devices to Participate in Upcoming Investor ConferencesNASDAQ:MASS908 Devices Inc
24/10/202420h02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MASS908 Devices Inc
22/10/202413h00Business Wire908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024NASDAQ:MASS908 Devices Inc
06/09/202413h00Business Wire908 Devices to Participate in Craig-Hallum Bioprocessing ConferenceNASDAQ:MASS908 Devices Inc
06/08/202415h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MASS908 Devices Inc
06/08/202413h00Business Wire908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue OutlookNASDAQ:MASS908 Devices Inc
30/07/202413h00Business Wire908 Devices to Participate in Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:MASS908 Devices Inc
23/07/202413h00Business Wire908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:MASS908 Devices Inc
09/07/202422h34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MASS908 Devices Inc
25/06/202413h00Business Wire908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of DirectorsNASDAQ:MASS908 Devices Inc
18/06/202413h00Business Wire908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and VaporsNASDAQ:MASS908 Devices Inc
30/05/202413h00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:MASS908 Devices Inc
30/04/202413h45Business Wire908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue OutlookNASDAQ:MASS908 Devices Inc
30/04/202413h30Business Wire908 Devices Acquires RedWave Technology, Expanding its Forensics Product OfferingNASDAQ:MASS908 Devices Inc
23/04/202413h00Business Wire908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:MASS908 Devices Inc
12/03/202422h45Business WireLa technologie d'identification chimique des traces de 908 Devices est adoptée par les agences européennesNASDAQ:MASS908 Devices Inc
12/03/202419h49Business WireDie Technologie zur Identifizierung chemischer Spuren von 908 Devices wird von europäischen Behörden eingeführtNASDAQ:MASS908 Devices Inc
12/03/202412h00Business Wire908 Devices Trace Chemical Identification Technology Adopted by European AgenciesNASDAQ:MASS908 Devices Inc
08/03/202423h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MASS908 Devices Inc
08/03/202422h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MASS908 Devices Inc
05/03/202413h00Business Wire908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue OutlookNASDAQ:MASS908 Devices Inc
29/02/202413h00Business Wire908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing PlatformNASDAQ:MASS908 Devices Inc
20/02/202413h00Business Wire908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:MASS908 Devices Inc
 Showing the most relevant articles for your search:NASDAQ:MASS

Dernières Valeurs Consultées

Delayed Upgrade Clock